~~<i id='0B4FAB3CC5'><strike id='0B4FAB3CC5'><tt id='0B4FAB3CC5'><pre id='0B4FAB3CC5'></pre></tt></strike></i>~~

Home» Wikipedia» hotspot

hotspot

author：knowledge 2025-09-27 13:01:27 Page View：712

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada
Next article： Heart attack and stroke risk calculators need revising

explore

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

GOP inquiry over gain

BernardMossCourtesyNIAIDFormorethanhalfacentury,scientistBernardMosshasbeencommandingtheattentionofp

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Leading voice in opioid treatment defends methadone clinic system

MarkParrino:"Idon’tthinkthedominantinterestisjustgivinglotsmoretake-homestopatients.There’smoretotre